US Patent Issued to ANAVEX LIFE SCIENCES on April 7 for "A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method for anti-seizure therapy" (New Jersey, New York Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,256, issued on April 7, was assigned to ANAVEX LIFE SCIENCES CORP. (New York).

"A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method for anti-seizure therapy" was invented by Christopher U. Missling (New York) and Cameron Durrant (Califon, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention concerns a dosage form comprising a therapeutically effective amount of A19-144 or A2-73 and a therapeutically effective amount of at least one AED. This invention further encompasses a method of treating a subject in need of such treatment comprising administering a therapeutically effective amount of A19-144 or A2-73 in...